A breakthrough in diabetes treatment. Poles have invented a revolutionary device for patients

A Polish start-up from Warsaw, Advanced Medical Equipment, has developed an innovative device that could change the lives of millions of diabetics around the world. Thanks to the non-invasive glucometer, which measures blood sugar levels without the need for puncturing, patients will be able to monitor their health in a much more convenient and less stressful way. To date, investors have allocated over PLN 3 million to develop this technology, and the company intends to obtain additional funds on the NewConnect market.

Non-invasive glucometer. No more finger pricking

In Poland, as many as 3.2 million people suffer from diabetes, and another 6 million are in a pre-diabetic state. This alarming number increases the need to create innovative medical solutions that will facilitate the daily functioning of patients. In response to these challenges, AME created the “diabetomat” – a smartphone-shaped device that non-invasively tests blood sugar levels. This innovation can not only help diabetics in daily health monitoring, but also find application in screening tests in hospitals and nursing homes.

It is estimated that in the next five years the global market for glucometers will reach 15 billion dollars. Currently, patients have to use invasive methods that involve blood collection, which is not only painful but also requires hygienic conditions. There are also semi-invasive solutions available on the market, such as smart patches with microneedles, but their use generates additional costs for patients, and in Poland they are not reimbursed. Meanwhile, the AME “diabetomat” is to revolutionize the market by eliminating the need for regular skin pricking.

The company has already secured funds for the project, but is now preparing for a stock market debut on NewConnect, valued at over PLN 42 million. The funds raised are to enable the medical certification process, which will pave the way for mass production. The start-up assumes that serial production will start within two years, and pre-market versions of devices are already being prepared.

The founders of AME, Artur Rydosz and prof. Konstanty Marszałek, emphasize that one of the key goals is to obtain medical certification, which will allow for the commercialization of the device. This process is crucial for introducing the diabetomat into medical procedures. The factory that is to be responsible for the production of the devices has already been selected and will be located near Warsaw. The company expects that after certification and the launch of test production, its market value may increase several times.

Global competition and Polish innovations

AME is not the only player on the non-invasive glucometer market. A dozen or so companies around the world, such as the German DiaMonTech or the Danish RSP Systems, are working on similar solutions based on light emission technology. However, Polish innovations in this area are also developing. The Center for Research and Development of Technologies for Industry is developing a glucose measurement system based on the analysis of exhaled air, which is to revolutionize the current methods of self-control.

In addition, the Polish company Biotts is working on a novel patch that delivers the drug semaglutide through the skin, and Nutrix is ​​developing gSense technology, which monitors glucose levels based on biomarkers contained in saliva and blood. Both of these solutions, like the diabetomat, aim to make life easier for people with diabetes, minimizing the pain and discomfort associated with daily blood sugar control.

Advanced Medical Equipment, by developing a non-invasive glucometer, has a chance to become a leader in the market of innovative medical technologies. Thanks to the support of investors and the planned debut on NewConnect, the company is preparing to implement its groundbreaking device into mass production. If it manages to obtain the appropriate certificates, the diabetomat could revolutionize the daily lives of millions of diabetics, not only in Poland, but all over the world.